Webinar: ACR/CHEST ILD Guidelines in Practice| Video: All the Lonely People

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hip OA

What Price Glory (or, at Least, Getting Your Foot in the Door)?

Gerald Eisenberg  |  

In many respects, this is the beginning of the golden age of rheumatology. Diagnostic and therapeutic approaches are now available that have radically altered for the better the lives of people with diseases that were considered virtually untreatable just a few years ago. The rheumatologist’s approach to patients with rheumatoid arthritis, the spondyloarthropathies, osteoporosis and…

ACR Pursues Solutions for Flawed MIPS Infusion Regulations & Billing Codes

  |  

While the latest version of the Republican-sponsored healthcare bill once again falters and its prospects of becoming the new law of the land fade, plenty of advocacy work is continuing on behalf of rheumatologists and rheumatology practices. The ACR, along with multiple partners, has renewed its push for regulatory relief in a number of areas…

Undetected Fractures Linked to Back Pain in Older Men

Shereen Lehman  |  

(Reuters Health)—About three in five older men with tiny spinal fractures related to osteoporosis reported new or worsening back pain in a new study. Only about one-quarter of new vertebral fractures are diagnosed by a doctor, the study team writes in their September 7 online report in Journal of Bone and Mineral Research, though the…

RISE Data Use to Be Highlighted at 2017 ACR/ARHP Annual Meeting

  |  

This year’s ACR/ARHP Annual Meeting, which takes place Nov. 3–8 in San Diego, features several opportunities to learn more about the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry, and the data and tools it offers rheumatologists. For the first time, RISE data will be presented at the Annual Meeting by rheumatologists outside of the ACR’s…

Skype-Based Biopsychosocial Treatments Help Save Physical Therapy Patients Time, Trouble

Elizabeth Hofheinz, MPH, MEd  |  

It’s a bit ironic that when injured people are in pain—and their mobility is reduced—they are often expected to travel to a physical therapy clinic. For millions of people, such trips are a burden. In Australia, however, some patients are “letting movement come to them.” Novel research from The University of Melbourne shows that taking…

Treat-to-Target Strategy Evaluated for Fibromyalgia Care

  |  

Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibro­myalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…

A CT scan of the chest showing multifocal ground-glass opacities, representative of hemorrhage, with numerous nodular interstitial opacities primarily within a peribronchovascular distribution.

Hemoptysis in a Young Indian Male

Payam Pourhassani, DO, MSc, Sneha Patel, MD, & Arundathi Jayatilleke, MD  |  

A 22-year-old Indian male presented to the emergency department with hemoptysis. A month prior, he had presented to an urgent care center complaining of cough with occasional episodes of blood-tinged sputum in the morning. He was diagnosed with community-acquired pneumonia based on a chest X-ray without laboratory testing and was prescribed levofloxacin. A few days…

Fellows’ Forum Case Report: Progressive Multifocal Leukoencephalopathy and RA

Eugene Jalbert, DO, MBA, Priyanka Murali, DO, Rakhee Shah, DO, Robert DiGiovanni, DO, FACOI, FACR, & Rubaiya Mallay, DO, FACOI, FACR  |  

Rheumatoid arthritis (RA) is a systemic autoimmune disease associated with erosive destruction of diarthrodial joints. Patients who are seropositive are more prone to developing extra-articular manifestations, such as rheumatoid lung, rheumatoid nodules and others. With the development of disease-modifying anti-rheumatic drugs (DMARDs), the incidence and severity of these extra-articular manifestations has declined. Below, we describe…

Support Rheumatic Disease Awareness Month in September

Sharad Lakhanpal, MBBS, MD  |  

Wider awareness and understanding of the more than 100 different rheumatic diseases is a vital element in our work as rheumatologists and rheumatology health professionals. Stimulating interest and engagement among lawmakers, patient groups and the public at large is essential to successful advocacy efforts, as well as the overall future of our specialty. This September,…